Department of Microbiology and Immunology, Division of Nephrology, University Hospitals Leuven, Belgium.
Clin J Am Soc Nephrol. 2013 Sep;8(9):1508-14. doi: 10.2215/CJN.00300113. Epub 2013 Jun 27.
p-Cresyl sulfate and indoxyl sulfate contribute to cardiovascular disease and progression of renal disease. Renal clearance of both solutes mainly depends on tubular secretion, and serum concentrations are widely dispersed for any given stage of CKD. From this information, it is inferred that estimated GFR is not a suitable proxy of the clearance of these solutes. Formal clearance studies have, however, not been performed to date.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study analyzed renal clearances of p-cresyl sulfate and indoxyl sulfate in the Leuven CKD cohort (NCT00441623; inclusion between November of 2005 and September of 2006) and explored their relationship with estimated GFR. Multivariate linear regression models were built to evaluate contributions of estimated GFR, demographics, and generation rates to p-cresyl sulfate and indoxyl sulfate serum concentrations.
Renal clearances were analyzed in 203 patients with CKD stages 1-5. Indoxyl sulfate clearances (median=17.7, interquartile range=9.4-33.2 ml/min) exceeded p-cresyl sulfate clearances (median=6.8, interquartile range=3.4-12.0 ml/min) by about threefold. A linear relationship was observed between estimated GFR and clearances of p-cresyl sulfate (R(2)=0.50, P<0.001) and indoxyl sulfate (R(2)=0.55, P<0.001). In multivariate regression, p-cresyl sulfate concentrations were associated (R(2)=0.75) with estimated GFR and generation rate (both P<0.001). Indoxyl sulfate concentrations were associated (R(2)=0.74) with estimated GFR, generation rate (both P<0.001), age (P<0.05), and sex (P<0.05).
Estimated GFR provides an acceptable estimate of renal clearance of p-cresyl sulfate and indoxyl sulfate. Remarkably, clearances of indoxyl sulfate exceed clearances of p-cresyl sulfate by approximately threefold, suggesting substantial differences between tubular transporter affinities and/or involvement of separate transporter systems for p-cresyl sulfate and indoxyl sulfate.
对甲酚硫酸盐和吲哚硫酸酯是心血管疾病和肾脏疾病进展的罪魁祸首。这两种溶质的肾清除主要依赖于肾小管分泌,并且对于任何特定的 CKD 阶段,血清浓度都广泛分散。根据这些信息,可以推断出估计的肾小球滤过率不是这些溶质清除率的合适替代物。但是,迄今为止尚未进行正式的清除研究。
设计、设置、参与者和测量:本研究分析了列日 CKD 队列(NCT00441623;纳入时间为 2005 年 11 月至 2006 年 9 月)中对甲酚硫酸盐和吲哚硫酸酯的肾清除率,并探讨了它们与估计肾小球滤过率的关系。建立了多元线性回归模型,以评估估计肾小球滤过率、人口统计学和生成率对血清对甲酚硫酸盐和吲哚硫酸酯浓度的贡献。
对 203 名 CKD 1-5 期患者进行了肾清除率分析。吲哚硫酸酯清除率(中位数=17.7,四分位距=9.4-33.2ml/min)比对甲酚硫酸盐清除率(中位数=6.8,四分位距=3.4-12.0ml/min)高出约三倍。观察到估计肾小球滤过率与对甲酚硫酸盐(R²=0.50,P<0.001)和吲哚硫酸酯(R²=0.55,P<0.001)的清除率之间存在线性关系。多元回归分析中,对甲酚硫酸盐浓度与估计肾小球滤过率(R²=0.75,P<0.001)和生成率(均 P<0.001)相关。吲哚硫酸酯浓度与估计肾小球滤过率(R²=0.74,P<0.001)、生成率(均 P<0.001)、年龄(P<0.05)和性别(P<0.05)相关。
估计肾小球滤过率可以很好地估计对甲酚硫酸盐和吲哚硫酸酯的肾清除率。值得注意的是,吲哚硫酸酯的清除率比对甲酚硫酸盐的清除率高出约三倍,这表明对甲酚硫酸盐和吲哚硫酸酯的肾小管转运体亲和力和/或涉及不同的转运体系统之间存在显著差异。